Mary K L Collins

Title: The Innovations of Mary K L Collins

Introduction

Mary K L Collins is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the development of retroviral vectors. His work has implications for gene therapy and other medical applications.

Latest Patents

Mary K L Collins holds a patent for "Retroviral vectors produced by producer cell lines resistant to lysis by human serum." This innovation involves retroviral vectors that are resistant to inactivation by human serum. The vectors are produced in cell lines that are resistant to lysis by human serum, including HOS, Mv-1-Lu, HT1080, TE671, and human 293 cell lines. These retroviral vectors are especially useful as in vivo gene delivery vehicles. He has 1 patent to his name.

Career Highlights

Throughout his career, Collins has focused on advancing the understanding and application of retroviral vectors in gene therapy. His research has contributed to the development of safer and more effective gene delivery methods.

Collaborations

Some of his notable coworkers include Michael Pensiero and Francois-Loic Cosset. Their collaborative efforts have furthered research in the field of retroviral vectors and gene therapy.

Conclusion

Mary K L Collins is a pioneering inventor whose work in retroviral vectors has the potential to transform gene therapy. His contributions continue to influence the field and inspire future innovations.